BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27793128)

  • 1. Defining cognitive impairment in people-living-with-HIV: the POPPY study.
    De Francesco D; Underwood J; Post FA; Vera JH; Williams I; Boffito M; Sachikonye M; Anderson J; Mallon PW; Winston A; Sabin CA;
    BMC Infect Dis; 2016 Oct; 16(1):617. PubMed ID: 27793128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIV.
    Underwood J; De Francesco D; Post FA; Vera JH; Williams I; Boffito M; Mallon PW; Anderson J; Sachikonye M; Sabin C; Winston A;
    HIV Med; 2017 May; 18(5):363-369. PubMed ID: 27785907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment.
    Underwood J; De Francesco D; Leech R; Sabin CA; Winston A;
    PLoS One; 2018; 13(4):e0194760. PubMed ID: 29641619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease.
    Wang Z; Molsberry SA; Cheng Y; Kingsley L; Levine AJ; Martin E; Munro CA; Ragin A; Rubin LH; Sacktor N; Seaberg EC; Becker JT;
    AIDS; 2019 Nov; 33(14):2115-2124. PubMed ID: 31335803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
    Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK;
    J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
    Delle Donne V; Ciccarelli N; Massaroni V; Borghetti A; Dusina A; Farinacci D; Visconti E; Tamburrini E; Fabbiani M; Di Giambenedetto S
    J Neurovirol; 2020 Dec; 26(6):899-907. PubMed ID: 32839950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.
    Milanini B; Catella S; Perkovich B; Esmaeili-Firidouni P; Wendelken L; Paul R; Greene M; Ketelle R; Valcour V
    AIDS Care; 2017 Sep; 29(9):1178-1185. PubMed ID: 28127989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia.
    Mukherjee T; Sakthivel R; Fong HY; McStea M; Chong ML; Omar SF; Chin AV; Kamaruzzaman S; Kamarulzaman A; Rajasuriar R; Cysique LA
    AIDS Behav; 2018 Oct; 22(10):3226-3233. PubMed ID: 29508103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.
    Kisakye A; Saylor D; Sacktor N; Nakigozi G; Nakasujja N; Robertson K; Anok A; Wawer M; Gray R
    AIDS Care; 2019 Jul; 31(7):836-839. PubMed ID: 30554522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
    Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
    J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Correlates of Subjective Cognitive Impairment in HIV Disease.
    Sheppard DP; Woods SP; Massman PJ; Gilbert PE
    AIDS Behav; 2019 Mar; 23(3):617-626. PubMed ID: 30311103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.
    De Francesco D; Underwood J; Bagkeris E; Boffito M; Post FA; Mallon P; Vera JH; Williams I; Anderson J; Johnson M; Sabin CA; Winston A;
    HIV Med; 2019 Apr; 20(4):274-285. PubMed ID: 30734983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individuals.
    De Francesco D; Underwood J; Anderson J; Boffito M; Post FA; Sachikonye M; Mallon PWG; Haddow L; Vera JH; Kunisaki KM; Sabin CA; Winston A
    AIDS Care; 2021 Oct; 33(10):1296-1307. PubMed ID: 33356492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study.
    Alford K; Daley S; Banerjee S; Vera JH
    PLoS One; 2021; 16(5):e0251944. PubMed ID: 34010362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV.
    Prats A; López-Masramon E; Pérez-Álvarez N; Garolera M; Fumaz CR; Ferrer MJ; Clotet B; Muñoz-Moreno JA
    J Assoc Nurses AIDS Care; 2019; 30(1):35-41. PubMed ID: 30586082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.
    Shirazi TN; Summers AC; Smith BR; Steinbach SR; Kapetanovic S; Nath A; Snow J
    AIDS Behav; 2017 Jul; 21(7):2124-2134. PubMed ID: 28108876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward.
    Nightingale S; Dreyer AJ; Saylor D; Gisslén M; Winston A; Joska JA
    Clin Infect Dis; 2021 Sep; 73(6):1113-1118. PubMed ID: 33904889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.